Innospec financials
$96.72−1.19%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $491.4M | $453.2M | $455.6M | $441.9M | $439.7M | $440.8M | $466.8M | $443.4M | $435.0M | $500.2M | $494.7M | $464.1M |
| Gross profit | $138.3M | $123.5M | $127.4M | $116.7M | $123.2M | $125.1M | $136.2M | $124.1M | $126.9M | $155.7M | $155.7M | $137.2M |
| Gross margin | 28.1% | 27.3% | 28.0% | 26.4% | 28.0% | 28.4% | 29.2% | 28.0% | 29.2% | 31.1% | 31.5% | 29.6% |
| Operating income | $39.7M | $31.8M | $46.8M | $5.9M | $34.2M | $43.1M | -$114.5M | $45.5M | $41.3M | $50.4M | $44.5M | $41.9M |
| Net income | $30.8M | $30.4M | $47.4M | $12.9M | $23.5M | $32.8M | -$70.4M | $33.4M | $31.2M | $41.4M | $37.8M | $39.2M |
| Net margin | 6.3% | 6.7% | 10.4% | 2.9% | 5.3% | 7.4% | −15.1% | 7.5% | 7.2% | 8.3% | 7.6% | 8.4% |
| Diluted EPS | $1.25 | $1.22 | $1.90 | $0.52 | $0.94 | $1.31 | $-2.79 | $1.33 | $1.24 | $1.65 | $1.50 | $1.57 |
| EBITDA | $49.7M | $41.7M | $56.2M | $61.0M | $45.3M | $54.0M | -$103.6M | $56.6M | $52.4M | $61.6M | $44.5M | $51.8M |
| Operating cash flow | $7.2M | $17.6M | $61.4M | $39.3M | $10.5M | $28.3M | $25.7M | $73.5M | $4.7M | $80.6M | $72.4M | $58.1M |
| Free cash flow | -$10.5M | $8.7M | $46.8M | $25.0M | -$2.5M | $19.9M | $13.6M | $65.8M | -$6.2M | $69.9M | $55.5M | $45.5M |
| Diluted shares | 24.7M | 24.8M | 24.9M | 24.9M | 25.0M | 25.1M | 25.2M | 25.1M | 25.1M | 25.1M | 25.1M | 25.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $250.2M | $289.1M | $292.5M | $270.8M | $266.6M | $299.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $1.85B | $1.82B | $1.83B | $1.80B | $1.81B | $1.77B |
| Total liabilities | $495.2M | $467.6M | $499.5M | $496.5M | $504.6M | $508.9M |
| Shareholders' equity | $1.35B | $1.35B | $1.33B | $1.30B | $1.30B | $1.27B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology